November 13, 2026
A conversation with web developer Zach Flauaus
Flauaus combines curiosity and a problem-solving mindset to build the school's digital presence and connect its work with the wider world.
People who are predisposed to cancer face high, lifelong costs for preventive care
People who learn that they are genetically predisposed to cancer can face a lifetime of medical procedures aimed at preventing disease or detecting it at an early stage when it is often more treatable. While potentially lifesaving, these procedures are costly and time-consuming, creating a significant burden for many people and an insurmountable obstacle for some.
In a new paper published in the journal Patient Education and Counseling, a team of researchers and patient advocates led by Mary Politi, PhD, a professor at the Andrew M. and Jane M. Bursky School of Public Health at Washington University in St. Louis, propose ways to address the financial burden of living with a cancer predisposition syndrome. First among them: changing health insurance coverage to include people at high risk. Insurance providers typically cover screening tests based on guidelines written for the general population, leaving those at high risk — who often need more frequent or more extensive monitoring — financially responsible for much of their preventive care.
“We want anyone who learns that they are at high risk to be able to take meaningful action to preserve their health,” said Politi, the paper’s senior author. "Those who can’t afford the preventive care recommended by their doctors face the anxiety of knowing they are at high risk without the ability to follow all screening and monitoring guidelines."
As part of the study, the researchers described the financial burden on Caroline, a hypothetical but realistic 30-year-old woman with Lynch syndrome. After her mother is diagnosed with colon cancer, Caroline learns that she and her mother both carry a mutation in a DNA-repair gene that puts them at risk of colorectal, endometrial (uterine) and other cancers. Upon the advice of her genetic counselor, Caroline undergoes a colonoscopy, which requires her to take a day and a half off work and costs $2,560 because her insurance does not cover the procedure for people her age. The test comes back normal, but Caroline will need to repeat it every one to two years indefinitely. People at average risk typically need a colonoscopy every 10 years starting at age 45.
That’s just the routine surveillance. Caroline and her partner want to have children, but don’t want to pass along the mutation. They consider in vitro fertilization with embryo testing, an expensive, invasive and time-consuming procedure, but finally decide they cannot afford it and go forward with having a baby without genetic testing. Once Caroline is done having children, she undergoes surgery to remove her uterus, ovaries and fallopian tubes to prevent future uterine and ovarian cancer. The surgery costs more than $4,000 out of pocket, requires weeks of recovery and sends Caroline into early menopause, which necessitates hormone replacement therapy and even more doctors’ visits.
“Knowing your risk is only the beginning. The screenings, procedures, time, costs and decisions that follow can continue for decades,” said co-author Sara Kavanaugh, a patient advocate who lives with Lynch syndrome. “Knowing your hereditary cancer risk can only improve outcomes if you can afford to act on that knowledge.”
The fictional Caroline is lucky, the authors note, because she can afford preventive care, despite the financial strain on her family. Not everyone can find a way to pay for what they need.
Politi and colleagues — including first author Christina Ping, a medical student at WashU Medicine — analyzed the financial barriers to accessing preventive care for people genetically predisposed for cancer, also called previvors. The team came up with four recommendations to reduce those barriers:
“There is a lot we can do to reduce the risk of cancer and improve outcomes, even for people who have a genetic predisposition for it,” Politi said. “These changes would help people take advantage of the medical knowledge we already have so they can protect themselves and have the best chance at living long and healthy lives.”
Ping C, Goldstein E, Chernet Y, Dean M, Westfall K, Housten AJ, Kavanaugh S, Politi MC. Living at risk and paying the price: The costs of hereditary cancer care in the United States. Patient Education and Counseling. December 2026. DOI: 10.1016/j.pec.2026.109837
The authors report no funders for this study.
Tamara Schneider, MPH, PhD, is the assistant director of communications and senior science writer at Bursky Public Health. She holds a bachelor’s degree in molecular biophysics & biochemistry and in sociology from Yale University, a master’s in public health from the University of California, Berkeley, and a PhD in biomedical science from the University of California, San Diego. She joined WashU as a science writer in 2016.
November 13, 2026
Flauaus combines curiosity and a problem-solving mindset to build the school's digital presence and connect its work with the wider world.
November 6, 2026
McQueen aims to understand what drives people’s health decisions and encourage healthier behaviors
November 6, 2026
Steensma travels to Malaysia to advance global collaboration on biodiversity, health and innovation